(125 days)
This Patient Monitor is a multi-functional instrument designed for monitoring the vital physiological signs of adult and pediatric (but not neonatal) patients. With the functions of real-time recording and displaying parameters, such as ECG, heart rate(HR), non-invasive blood pressure (NIBP), functional oxygen saturation (SpO2), respiration rate (RESP), body temperature (TEMP), end-tidal CO2 concentration (EtCO2), it allows comprehensive analysis of patient's physiological conditions.
This instrument is applicable for use in hospitals and clinical institutions. The operation should be performed by qualified professionals only.
This Patient Monitor is a multi-functional instrument designed for monitoring the vital physiological signs of adult and pediatric (not neonatal) patients. With the functions of real-time recording and displaying parameters, such as ECG, pulse rate (PR), noninvasive blood pressure (NIBP), functional oxygen saturation (SpOz), respiration rate (RESP), body temperature (TEMP), end-tidal CO2 concentration (EtCO2), it allows comprehensive analysis of patient's physiological conditions.
This instrument is applicable for use in hospitals and clinical institutions. The operation should be performed by qualified professionals only.
There are three versions of the K serial Patient Monitor, K10, K12 and K15. The primary difference is physical dimension and display TFT size; all other specifications remain unchanged. All versions have the same indications for use.
This document, a 510(k) summary for the Shenzhen Creative Industry Co., Ltd. Patient Monitor, Models K10, K12, and K15, primarily focuses on demonstrating substantial equivalence to a predicate device (Shenzhen Creative Industry UP-7000 Patient Monitor, K123711) rather than detailing the specific acceptance criteria and study proving performance for a novel AI/software device.
Therefore, much of the requested information regarding AI device performance (e.g., sample sizes for training/test sets, expert adjudication, MRMC studies, standalone performance, ground truth establishment for training) is not applicable or present in this document. This document describes a traditional medical device (patient monitor) and its components, and the "study" referred to is non-clinical and clinical testing to ensure compliance with relevant performance standards for vital sign monitoring.
However, I can extract the information that is applicable based on the provided text, particularly focusing on the performance criteria for the integrated vital sign modules.
Here's an analysis based on the provided text:
Device: Patient Monitor, Models K10, K12, K15
Indications for Use: Monitoring the vital physiological signs of adult and pediatric (but not neonatal) patients, including ECG, heart rate (HR), non-invasive blood pressure (NIBP), functional oxygen saturation (SpO2), respiration rate (RESP), body temperature (TEMP), and end-tidal CO2 concentration (EtCO2). Applicable for use in hospitals and clinical institutions, operation by qualified professionals only.
Study Type: This is a 510(k) submission seeking substantial equivalence to a predicate device. The "studies" involve non-clinical (safety and performance) and clinical (NIBP validation) testing against recognized standards rather than a comparative effectiveness study of a novel AI algorithm's diagnostic performance.
1. Table of acceptance criteria and the reported device performance:
The document lists performance specifications for each physiological parameter module, often directly comparing them to the predicate device. The acceptance criteria are implicitly that the devices meet or are substantially equivalent to the established performance requirements of the predicate device and relevant industry standards.
| Characteristic | Acceptance Criteria (Predicate) | Reported Device Performance (Subject Device) | Difference Discussion (Relevance) |
|---|---|---|---|
| SpO2 Accuracy | Adult & Pediatric: ±3% (70%-100%), Undefined (0-70%) | Adult & Pediatric: ±3% (70%-100%), Undefined (0-70%) | No change. |
| Pulse Rate Accuracy (SpO2) | ±2 bpm or ±2% (whichever is greater) | ±2 bpm or ±2% (whichever is greater) | No change. |
| CO2 Accuracy (0-40 mmHg) | ±2 mmHg | ±2 mmHg | No change. |
| CO2 Accuracy (41-70 mmHg) | ±5% of reading | ±5% of reading | No change. |
| CO2 Accuracy (71-100 mmHg) | ±8% of reading | ±8% of reading | No change. |
| CO2 Accuracy (101-150 mmHg) | ±10% of reading | ±10% of reading | No change. |
| Respiration Rate Accuracy (CO2) | ±2 rpm | ±2 rpm | No change. |
| Heart Rate Precision (ECG) | ±1% or ±2 bpm, whichever is greater | ±1% or ±2 bpm, whichever is greater | No change. |
| RESP Rate Accuracy | ±2% or ±2 rpm, whichever is greater | ±2% or ±2 rpm, whichever is greater | No change. |
| NIBP BP Accuracy (Mean Deviation) | ±5 mmHg | Max. mean deviation values: ±5 mmHg | Identical. |
| NIBP BP Accuracy (Standard Deviation) | <= 8 mmHg | Max. standard deviation: 8 mmHg | Identical. |
| Temperature Measurement Accuracy | ±0.1C (35.0C-39.0C); ±0.2C (rest) | ±0.2C (25.0C-45.0C); ±0.4C (rest) | Difference noted, but stated to "not raise any new questions of safety and effectiveness and still complies with the ISO80601-2-56 requirement." |
| NIBP Overpressure Protector (Adult Cuff Pressure) | Cuff pressure exceeds 300mmHg | Cuff pressure exceeds 300mmHg | Identical. |
| NIBP Overpressure Protector (Pediatric Cuff Pressure) | Cuff pressure exceeds 300mmHg | Cuff pressure exceeds 240mmHg | Subject device is more stringent (lower max pressure). |
Note: The document explicitly states for the NIBP and TEMP modules that "The new [module] used in subject devices complies with the same ISO [standard] and design requirement as Predicate device." This implies the acceptance criterion for these components is compliance with the cited ISO standards (e.g., ISO 80601-2-30 for NIBP, ISO 80601-2-56 for TEMP).
2. Sample size used for the test set and the data provenance:
- Test Set Sample Size:
- For NIBP (Non-invasive sphygmomanometers) clinical validation (ISO 81060-2), this standard typically requires a minimum of 85 subjects (adults and children combined) for a full validation. While the exact number isn't stated in the provided text, the reference to this specific standard implies adherence to its sample size requirements.
- For other parameters (SpO2, CO2, ECG, RESP, TEMP), the "performance data" section refers to IEC/ISO standards (e.g., 60601-2-49, 80601-2-61, 80601-2-55, 60601-2-27, 80601-2-56). These standards define particular requirements for the performance of the devices and often involve bench testing, simulations, or phantom studies rather than large-scale human clinical trial "test sets" in the AI sense.
- Data Provenance: Not specified in the provided text (e.g., country of origin). The testing is referred to as "Non-Clinical Study" and "Clinical Study" without detail on whether retrospective or prospective data was used, except for the NIBP clinical validation which would be prospective.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not Applicable in the AI/Software Sense: This document describes a traditional patient monitor. The "ground truth" for a patient monitor's vital sign measurements is established against recognized reference measurement methods or calibrated instruments (e.g., a known SpO2 reading from a CO-oximeter, a calibrated pressure sensor for NIBP, or a physiological simulator for ECG).
- For NIBP (ISO 81060-2): This standard for clinical validation of automated sphygmomanometers typically requires measurements to be taken by trained observers (not necessarily "experts" in the diagnostic sense, but highly skilled in manual auscultatory measurements) and compared against a reference standard. The number of observers is also specified in the standard (e.g., at least 3 observers taking sequential measurements). Their "qualification" would be their training and demonstrated proficiency in the reference method.
4. Adjudication method for the test set:
- Not Applicable in the AI/Software Sense: There is no "adjudication" of expert interpretations as seen in AI studies, as the device measures physiological parameters directly.
- For NIBP (ISO 81060-2): The standard defines specific statistical methods for comparing the device's measurements to the reference measurements, often involving Bland-Altman analysis and calculating mean difference and standard deviation. There's no "adjudication" in the sense of resolving conflicting human interpretations; rather, it's a statistical comparison to a pre-defined reference.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not Applicable: This device is a patient monitor, not an AI diagnostic imaging tool or a system that assists human "readers" with interpretation. Therefore, no MRMC study was performed or is relevant to this submission.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Not Applicable in the AI/Software Sense: The described device functions as a standalone vital sign monitor. Its "performance" is inherently "algorithm only" in that its internal processing generates the vital sign values. However, this is not an "AI algorithm" in the context of complex pattern recognition or decision support. The performance is assessed by comparing its output against reference standards, which is a form of standalone evaluation for a monitor.
7. The type of ground truth used:
The ground truth for the performance evaluations of this patient monitor would be derived from:
-
Reference Measurements/Calibrated Standards:
- Physiological Simulators: For ECG, RESP, and potentially SpO2 and NIBP, to generate known, controlled physiological signals.
- Calibrated Instruments: For SpO2 (e.g., CO-oximeter), CO2 (calibrated gas mixtures), NIBP (auscultatory measurements by trained observers or calibrated pressure transducers), and Temperature (calibrated thermometers).
- In-vitro/Bench Testing: As implied by adherence to IEC/ISO performance standards, which often dictate specific test setups and reference instruments.
-
Clinical Data (for NIBP): As per ISO 81060-2, the ground truth for NIBP accuracy relies on trained human observers taking simultaneous or sequential auscultatory blood pressure measurements (the "reference method").
8. The sample size for the training set:
- Not Applicable: This device is a traditional patient monitor, not an AI/machine learning device that requires a "training set" in the context of deep learning models. Its algorithms are based on established physiological signal processing principles.
9. How the ground truth for the training set was established:
- Not Applicable: As stated above, there is no "training set" for this type of device. The ground truth for its performance verification (as opposed to AI training) is established using validated, calibrated reference standards and methods as described in point 7.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
December 31, 2019
Shenzhen Creative Industry Co., Ltd. % Charlie Mack Principal Engineer IRC 2950 E Lindrick Drive Chandler, Arizona 85249
Re: K192343
Trade/Device Name: Patient Monitor, Models K10, K12 and K15 Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive Blood Pressure Measurement System Regulatory Class: Class II Product Code: DXN, DQA, CCK, FLL, MWI Dated: November 17, 2019 Received: November 26, 2019
Dear Charlie Mack:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
{1}------------------------------------------------
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for
Stephen Browning Acting Assistant Director DHT2A: Division of Cardiac Electrophysiology, Diagnostics and Monitoring Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K192343
Device Name Patient Monitor, Models K10, K12, K15
Indications for Use (Describe)
This Patient Monitor is a multi-functional instrument designed for monitoring the vital physiological signs of adult and pediatric (but not neonatal) patients. With the functions of real-time recording and displaying parameters, such as ECG, heart rate(HR), non-invasive blood pressure (NIBP), functional oxygen saturation (SpO2), respiration rate (RESP), body temperature (TEMP), end-tidal CO2 concentration (EtCO2), it allows comprehensive analysis of patient's physiological conditions.
This instrument is applicable for use in hospitals and clinical institutions. The operation should be performed by qualified professionals only.
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for Creative Medical. The logo consists of a blue square made up of four smaller squares, each containing a hand with three fingers. To the right of the square is the text "CREATIVE MEDICAL" in blue, with "CREATIVE" on top and "MEDICAL" on the bottom.
Shenzhen Creative Industry Co., Ltd.
510(k) Summary (21 CFR §807.92)
Submitter Information:
| Submitter Name: | Shenzhen Creative Industry Co., Ltd. |
|---|---|
| Address: | Floor 5, BLD 9, Baiwangxin High-Tech Industrial Park,Songbai Road, Xili Street, Nanshan District, Shenzhen,PR China 518110 |
| Telephone: | +86-755-26433325 |
| Fax: | +86-755-26435433 |
| Contact Person: | Ms. Jia WangGeneral Manager |
| Email: | charliemack@irc-us.com |
Date of Preparation: December 26, 2019
{4}------------------------------------------------
Subject Devices :
Trade/proprietary name: Patient Monitor, Models K10, K12, K15 Common Name: Patient Monitor
Classification
| Function | ProductCode | CFR | Panel |
|---|---|---|---|
| SpO2 | DQA | 870.2700 | Anesthesiology |
| CO2 | CCK | 868.1400 | Anesthesiology |
| ECG/RESP | MWI | 870.2300 | Cardiovascular |
| NIBP | DXN | 870.1130 | Cardiovascular |
| TEMP | FLL | 880.2910 | General Hospital |
Predicate Devices :
Trade Name: UP-7000 Patient Monitor
510(k) Reference: K123711
Common Name: Patient Monitor
Regulation Number:
| Function | Product Code | CFR | Panel |
|---|---|---|---|
| SpO2 | DQA | 870.2700 | Anesthesiology |
| CO2 | CCK | 868.1400 | Anesthesiology |
| ECG/RESP | MWI | 870.2300 | Cardiovascular |
| NIBP | DXN | 870.1130 | Cardiovascular |
| TEMP | FLL | 880.2910 | General Hospital |
Regulatory Class: Class II
Manufacturer:
Shenzhen Creative Industry Co., LTD.
{5}------------------------------------------------
Purpose of Submission
This is a new traditional 510(K) submission of Patient Monitor, Models K10, K12, K15.
Device Description
Overview
This Patient Monitor is a multi-functional instrument designed for monitoring the vital physiological signs of adult and pediatric (not neonatal) patients. With the functions of real-time recording and displaying parameters, such as ECG, pulse rate (PR), noninvasive blood pressure (NIBP), functional oxygen saturation (SpOz), respiration rate (RESP), body temperature (TEMP), end-tidal CO2 concentration (EtCO2), it allows comprehensive analysis of patient's physiological conditions.
This instrument is applicable for use in hospitals and clinical institutions. The operation should be performed by qualified professionals only.
There are three versions of the K serial Patient Monitor, K10, K12 and K15. The primary difference is physical dimension and display TFT size; all other specifications remain unchanged. All versions have the same indications for use.
Features
This monitoring system may be used to monitor a patient's physical parameters as followed: End-tidal Carbon Dioxide (EtCO2), Forced inspiratory carbon dioxide (FiCO2), ECG, heart rate, non-invasive blood pressure (NIBP), Respiratory Rate(RR), body temperature(TEMP), Pulse Oxygen Saturation (SpOz) and Pulse Rate(PR).
- . It can measure SpO2, Pulse Rate, and Perfusion Index displays on the LCD.
- It can measure End-tidal CO2 (EtCO2), FiCO2, and Respiration Rate. The CO2 . waveform displays on the LCD.
- . lt can measure ECG, heart rate, and Respiration Rate(RR). Which enables simultaneous monitoring of several ECG waveforms and display on the LCD.
- It can measure non-invasive blood pressure(NIBP) and body . temperature(TEMP); the measured value can be displayed on LCD.
{6}------------------------------------------------
- . Real-time monitoring of battery capacity, when the battery power is insufficient, low battery voltage alarm indication displays on the LCD screen.
- The customer could use either mainstream or sidestream for the same monitor.
- Two operating modes: normal monitoring and power-saving mode.
- Flexible menu setup and audible/visual alarm function.
- . It is battery powered and can also be powered by an AC mains power supply.
- . The built-in printer is optional.
Indication for use
This Patient Monitor is a multi-functional instrument designed for monitoring the vital physiological signs of adult, pediatric (but not neonatal) patients. With the functions of real-time recording and displaying parameters, such as ECG, Heart rate (HR), non-invasive blood pressure (NIBP), functional oxygen saturation (SpO2), respiration rate (RESP), body temperature (TEMP), end-tidal CO2 concentration (EtCO2), it allows comprehensive analysis of patient's physiological conditions.
This instrument is applicable for use in hospitals and clinical institutions. The operation should be performed by qualified professionals only.
Comparison with the predicate device:
Shenzhen Creative Industry Co., Ltd. believes that the Shenzhen Creative Industry Co., Ltd. Patient Monitor, Models K10, K12, K15 is substantially equivalent to the Shenzhen Creative Industry UP-7000 Patient Monitor (K123711). General Specifications (physical/electrical and operational properties) Remark: For the subject K serial Patient Monitor, there are three variations K10, K12, K15; The primary is physical dimension and display TFT size, all other specification remain unchanged. They have the same indications for use. The minor differences in the technological characteristics do not raise issues of safety and effectiveness. The subject device is identical to the predicate device. Please refer to the following pages for specific difference details.
{7}------------------------------------------------
Comparison to Predicate Devices
| Characteristics | Submitted Device | Predicate Device | Difference Discussion | |
|---|---|---|---|---|
| Physical dimension(mm)/weight(kg) | K10: 295mm(L)x178mm(D)x334mm(H)/4.5kgK12: 313mm(L)x178mm(D)x334mm(H)/5.2kgK15: 357mm(L)x178mm(D)x334mm(H)/5.7kg | 300 (L) x150 (D) x290 (H)/ 5.2kg | The physical dimension difference does notraise any new questions of safety andeffectiveness. | |
| Display | K15: 26.4cm(15") TFTK12: 30.7cm(12.1") TFTK10: 26.4cm(10.4") TFT | 12.1" Color TFT | The display dimension difference does notraise any new questions of safety andeffectiveness. | |
| Type, Degree ofprotection against electricshock | Class I with internal electric power supply.Where the integrity of the externalprotective earth(ground) in the installationor its conductors is in doubt, theequipment shall be operated from itsinternal electric power supply(batteries)CO2: BF(defibrillation proof)ECG/RESP/TEMP/SPO2/NIBP:CF(defibrillation proof) | Class I with internal electric power supply.Where the integrity of the externalprotective earth (ground) in the installationor its conductors is in doubt, the equipmentshall be operated from its internal electricpower supply(batteries)CO2: BF(defibrillation proof)ECG/RESP/TEMP/SPO2/NIBP:CF(defibrillation proof) | Identical | |
| Power supply | Battery or AC | Battery or AC | Identical | |
| AC Power Supply | 100~240V 50/60Hz 65VA | 100~240V 50/60Hz 100VA | The subject devices are powered by anexternal adapter and lithium battery whichfull match the design requirement andcomplying the applicable standards,including IEC60601-1, IEC60601-1-2, andIEC62133 | |
| Internal power source | Rechargeable Sealed Li-ion battery 11.1V4.4AH | Rechargeable sealed lead-acid battery,12V 2.3AH | The subject devices are powered by anexternal adapter and lithium battery whichfull match the design requirement andcomplying the applicable standards,including IEC60601-1, IEC60601-1-2, andIEC62133 | |
| Characteristics | Submitted Device | Predicate Device | Difference Discussion | |
| Battery charging indicator | Yes | Yes | Identical | |
| Low battery indicator | Yes | Yes | Identical | |
| Battery charge time, typical | Maximum 13~15 hours for charging | Maximum 13~15 hours for charging | Identical | |
| Flammable anesthetics | N/A | N/A | Identical | |
| Operating condition | Temperature: 5C–40C:Humidity: 30%—80%,non-condensingAtmospheric pressure: 70kPa–106.0kPa | Temperature: 5C–40C;Humidity: 30%—80%,non-condensingAtmospheric pressure: 70kPa–106.0kPa | Identical | |
| Storage condition | Temperature: -20C–60C:Humidity: 10%—95%,non-condensingatmosphere: 53kPa–106kPa | Temperature: -20C–60C;Humidity: 10%—95%,noncondensingatmosphere: 53kPa–106kPa | Identical | |
| EMC | The equipment meets the requirements ofIEC 60601-1-2:2014 | The equipment meets the requirements ofIEC 60601-1-2:2007 | Identical | |
| Power-on self-test | Yes | Yes | Identical | |
| Optional printer | Yes | Yes | Identical |
{8}------------------------------------------------
{9}------------------------------------------------
- SPO₂- Same as in Predicate Device
| Characteristics | Submitted Device | Predicate Device | Difference Discussion | |
|---|---|---|---|---|
| Name and model | Patient Monitor, Models K10, K12, K15 | UP-7000 Patient Monitor | N/A | |
| Manufacturer | Shenzhen Creative Industry Co., Ltd. | Shenzhen Creative Industry Co., Ltd. | N/A | |
| 510(K) Number: | N/A | K123711 | N/A | |
| SPO2 module | Creative SPO2 module KM-SPO-03(AFE) with the same principle as UP-7000(K123711)Creative SPO2 sensor only | Creative SPO2 module KM-SPO-03(AFE) with the same principle as PC-60(K063641)Creative SPO2 sensor only | No change | |
| Patient type | Adult, pediatric (but not neonatal) patients | Adult, pediatric patients | No change | |
| SPO2 display range | 0%~100% | 0%~100% | No change | |
| SPO2 measurement accuracy | Adult and Pediatric (but not neonatal): ±3% (during 70% | Adult and Pediatric: ±3% (during 70% | No change | |
| Alarm range (%) | High Limit: 1%~100% Lower Limit. 0%~99% | High Limit: 1%~100% Lower Limit. 0%~99% | No change | |
| Pulse rate measurement range | 30 bpm~240 bpm | 30 bpm~240 bpm | No change | |
| Pulse rate accuracy | ±2bpm or ±2% (whichever is greater) | ±2bpm or ±2% (whichever is greater) | No change | |
| Alarm range-Pulse rate (bpm) | High Limit: 1bpm | High Limit: 1bpm | No change | |
| Characteristics | Submitted Device | Predicate Device | Difference Discussion | |
| Name and model | Patient Monitor, Models K10, K12, K15 | UP-7000 Patient Monitor | N/A | |
| Manufacturer | Shenzhen Creative Industry Co., Ltd. | Shenzhen Creative Industry Co., Ltd. | N/A | |
| 510(K) Number: | N/A | K123711 | N/A | |
| CO2 module | Respironics LoFloTM EtCO2 (Side-stream) Module(K053174) andCAPNOSTAT 5 EtCO2 (Main-stream)Module(K042601) | Respironics LoFIoTM EtCO2 (Side-stream)Module(K053174) and CAPNOSTAT 5EtCO2 (Main-stream) Module(K042601) | No change | |
| CO2 measurement method | Infrared absorption method | Infrared absorption method | No change | |
| CO2 measure mode | Sidestream or Mainstream | Sidestream or Mainstream | No change | |
| Measuring parameters | EtCO2, FiCO2 and Respiration Rate | EtCO2, FiCO2 and Respiration Rate | No change | |
| CO2 Response Time | Sidestream: <3seconds (includestransport time and rise time).Mainstream: < 60ms (rise time) | Sidestream: <3seconds (includes transporttime and rise time).Mainstream: < 60ms (rise time) | No change | |
| Units | mmHg, kPa or Vol% | mmHg, kPa or Vol% | No change | |
| CO2 measure range | EtCO2: 0 | EtCO2: 0 | No change | |
| CO2 Resolution | 0.1mmHg (0 | 0.1mmHg (0 | No change | |
| CO2 Accuracy | 0 | 0 | No change | |
| Respiration Rate measurerange | 2 | 2 | No change | |
| Respiration Rate resolution | 1 rpm | 1rpm | No change | |
| Respiration Rate accuracy | $\pm$ 2rpm | ±2rpm | No change | |
| Flow Rate | 50ml/min ±10 ml/min (Sidestream) | 50ml/min ±10 ml/min (Sidestream) | No change | |
| No Breath Alarm Delay | 10~60s | 10~60s | No change | |
| Alarm adjustment range ofEtCO2 | High Limit: 1mmHg | High Limit: 1mmHg | No change | |
| Alarm adjustment range ofRR | High Limit: 1bpm | High Limit: 1bpm | No change | |
| Characteristics | Submitted Device | Predicate Device | Difference Discussion | |
| Name and model | Patient Monitor, Models K10, K12, K15 | UP-7000 Patient Monitor | N/A | |
| Manufacturer | Shenzhen Creative Industry Co., Ltd. | Shenzhen Creative Industry Co., Ltd. | N/A | |
| 510(K) Number: | N/A | K123711 | N/A | |
| ECG Module | Creative ECG/RESP module;ECG Cable cleared under K082959 ofUNIMED MEDICAL SUPPLIES INC. | Creative ECG/RESP module;ECG Cable cleared under K082959 ofUNIMED MEDICAL SUPPLIES INC. | No change | |
| Lead | AHA, EURO | AHA, EURO | No change | |
| Lead option | Yes | Yes | No change | |
| Gain | 2.5mm/mV(x0.25) 5mm/mV(x0.5),10mm/mV(x1), 20mm/mV(x2) ,40mm/mV(x4)and AUTO | 2.5mm/mV(x0.25) 5mm/mV(x0.5),10mm/mV(x1), 20mm/mV(x2) ,40mm/mV(x4)and AUTO | No change | |
| Sweep speed | 6.25mm/s, 12.5mm/s, 25mm/s, 50mm/s | 12.5mm/s, 25mm/s, 50mm/s | Similar | |
| Range of heart ratemonitoring | 15 bpm ~ 350 bpm | 15 bpm ~ 350 bpm | No change | |
| Resolution | 1bpm | 1bpm | No change | |
| Precision | ±1% or ± 2 bpm, whichever is greater. | ±1% or ± 2 bpm, whichever is greater. | No change | |
| Alarm setting | Adult high Limit: (1 | Adult high Limit: (1 | No change | |
| Input resistance | 2: 10MO(differential) | 2: 5MO(single ended) | Similar | |
| CMRR | Diagnostic mode: 2: 90dBMonitor mode: 2: 105dBOperation mode: 2: 105dB | Diagnostic mode: 2: 90dBMonitor mode: 2: 105dBOperation mode: 2: 105dB | No change |
{10}------------------------------------------------
- CO2 - Same as in Predicate Device
{11}------------------------------------------------
4. ECG – Same as in Predicate Device
{12}------------------------------------------------
| Characteristics | Submitted Device | Predicate Device | Difference Discussion |
|---|---|---|---|
| Anti-polarized voltage | +/-300mV | +/-300mV | No change |
| ECG mode | Monitoring, Diagnostic, Operation | Monitoring, Diagnostic | Added one "Operation" mode,and the difference does notraise any new questions ofsafety and effectiveness andstill complies with the IEC60601-2-27 requirementsame as Predicate device. |
| Frequency characteristic | Monitoring mode: 0.67Hz-40 HzDiagnostic mode: 0.05 Hz-75 HzOperation mode:1Hz-20Hz | Monitoring mode: 0.5 Hz-40 HzDiagnostic mode: 0.05 Hz-75 Hz | A little difference in frequencycharacteristic but it does notraise any new questions ofsafety and effectiveness andstill complies with the IEC60601-2-27 requirementsame as Predicate device. |
| Safeguard | CF | CF | No change |
{13}------------------------------------------------
5.RESP – Same as in Predicate Device
| Characteristics | Submitted Device | Predicate Device | Difference Discussion |
|---|---|---|---|
| Name and model | Patient Monitor, Models K10, K12, K15 | UP-7000 Patient Monitor | N/A |
| Manufacturer | Shenzhen Creative Industry Co., Ltd. | Shenzhen Creative Industry Co., Ltd. | N/A |
| 510(K) Number: | N/A | K123711 | N/A |
| RESP Module | Creative ECG/RESP module;ECG Cable cleared under K082959 ofUNIMED MEDICAL SUPPLIES INC. | Creative ECG/RESP module;ECG Cable cleared under K082959 ofUNIMED MEDICAL SUPPLIES INC. | No change |
| Lead | Optional: lead I and lead II; default lead II | Optional: lead I and lead II; default lead II | No change |
| Measurement technique | Thoracic impedance | Thoracic impedance | No change |
| Sweep speed | 6.25mm/s,12.5mm/s, | 6.25mm/s,12.5mm/s, | No change |
| Respiration excitationWaveform | <300uA, sinusoid, 75kHz (±10%) | <300uA, sinusoid, 75kHz (±10%) | No change |
| Respiration impedance testRange | 0.3 to 3 O | 0.3 to 3 O | No change |
| Baseline impedance range | 200 to 2500O(using an ECG cable with1kO resistance) | 200 to 2500O(using an ECG cable with 1kOresistance) | No change |
| Differential inputimpedance | >2.5 MO | >2.5 MO | No change |
| Linear Signal Range | 3O p-p minimum | 3O p-p minimum | No change |
| Bandwidth | 0.2 to 2Hz(-3 dB) | 0.2 to 2Hz(-3 dB) | No change |
| RESP rate measuringrange | 0rpm~120rpm | 0rpm~120rpm | No change |
| RESP rate accuracy | ±2% or ±2 rpm, whichever is greater | ±2% or ±2 rpm, whichever is greater | No change |
{14}------------------------------------------------
6. NIBP – New NIBP Module
| Characteristics | Subject Device | Predicate Device | Difference Discussion |
|---|---|---|---|
| Name and model | Patient Monitor, Models K10, K12, K15 | UP-7000 Patient Monitor | N/A |
| Manufacturer | Shenzhen Creative Industry Co., Ltd. | Shenzhen Creative Industry Co., Ltd. | N/A |
| 510(K) Number: | N/A | K123711 | N/A |
| NIBP module | KM-NIBP-12V02/SMD | SunTech Advantage 2.0 NIBP Module | The new NIBP module used insubject devices complies with thesame IEC80601-2-30 standardsand design requirement asPredicate device. |
| Method | Oscillometric method | Oscillometric method | Identical |
| Patient type | Adult and Pediatric (not neonatal): patients | pediatric and adult patients | Identical |
| Unit of measure | mmHg & kPa | mmHg & kPa | Identical |
| Pressure measurement | Adult: 40 ~ | Adult: 40 ~ 260mmHg | The new NIBP module used in |
| range - Systolic | pediatric (not neonatal):: 40 ~200mmHg | pediatric: 40 ~ 160mmHg | subject devices has little differencein measurement range, but stillcomplying with the sameIEC80601-2-30 standards anddesign requirement as Predicatedevice. |
| Pressure measurementrange - Diastolic | Adult: 10 ~ 210mmHgpediatric (not neonatal):: 10 ~150mmHg | Adult: 20 ~ 200mmHgpediatric: 20 ~ 120mmHg | The new NIBP module used insubject devices has little differencein measurement range, but stillcomplying with the sameIEC80601-2-30 standards anddesign requirement as Predicatedevice. |
{15}------------------------------------------------
| Characteristics | Subject Device | Predicate Device | Difference Discussion | |
|---|---|---|---|---|
| Pressure measurementrange-Mean pressure | Adult: 20 ~ 230mmHgpediatric (not neonatal):: 20 ~ 165mmHg | Adult: 26 ~ 220mmHgpediatric: 26 ~ 133mmHg | The new NIBP module used in subjectdevices has little difference inmeasurement range, but still complyingwith the same IEC80601-2-30 standardsand design requirement as Predicatedevice. | |
| 53 | BP accuracy | Max. mean deviation values: $\pm$ 5 mmHg;Max. standard deviation: 8 mmHg. | mean deviation values: $\pm$ 5 mmHg;Standard deviation: <= 8 mmHg. | Identical |
| Standard compliance | IEC/ISO 80601-2-30:2009+A1:2013ANSI/AAMI/ISO 81060-2:2009 | Meets ANSI/AAMI SP10:2002,EN1060-4:2004 | The new NIBP module complies with thenew FDA recognized standards. | |
| Cuff pressure range | 0 to 300mmHg | 0 to 300mmHg | Identical | |
| Overpressure protector | Internal operating software ensures that:-Maximum cuff inflation time is limitedto 50 seconds (Adult mode), 35seconds (Pediatric (not neonatal):mode) Duration of blood pressure reading islimited to 120 seconds (Adult mode), 90seconds (Pediatric (not neonatal): mode) Additional redundant safety circuitryoversees the normal operation andoverrides to abort a reading if: cuffpressure exceeds 300mmHg (Adultmode) or 240mmHg (Pediatric (notneonatal):mode) at any time. The cuffhas been inflated for 180 seconds(Adult & Pediatric (notneonatal):modes) | Internal operating software ensures that:--Maximum cuff inflation time islimited to 75 seconds Duration of blood pressure readingis limited to 130 seconds (Adultmode), 90 seconds (Pediatricmode) Additional redundant safety circuitryoversees the normal operation andoverrides to abort a reading if:Cuff pressure exceeds 300mmHg(Adult & Pediatric modes)at anytime. The cuff has been inflated for 180seconds (Adult & Pediatricmodes). | The Maximum cuff inflation time (Adultmode) of the subject device is shorterthan the Predicate device. The bloodpressure reading time (adult mode) isshorter than the Predicate device.The difference does not raise any newquestions of safety and effectiveness. |
{16}------------------------------------------------
| Characteristics | Subject Device | Predicate Device | DifferenceDiscussion | ||
|---|---|---|---|---|---|
| Alarmsetup | Systolic | HighLimit | Adult: 30 | Adult: 31 | Similar |
| LowerLimit | Adult: 29 | Adult: 29 | Identical | ||
| Diastolic | HighLimit | Adult : 11 | Adult : 11 | Identical | |
| LowerLimit | Adult : 10 | Adult : 10 | Identical | ||
| Alarm method | Sound light alarm, and record the alarmstatus for review | Sound light alarm, and record the alarmstatus for review | Identical |
{17}------------------------------------------------
7. TEMP – New TEMP Module
| Characteristics | Subject Device | Predicate Device | Difference Discussion |
|---|---|---|---|
| Name and model | Patient Monitor, Models K10, K12, K15 | UP-7000 Patient Monitor | N/A |
| Manufacturer | Shenzhen Creative Industry Co., Ltd. | Shenzhen Creative Industry Co., Ltd. | N/A |
| 510(K) Number: | N/A | K123711 | N/A |
| TEMP Module | KRK-TEMP PCBA 601S-E3 | Clinical electronic Thermometers (K982140) | The new TEMP module used in subjectdevices complies with the sameISO80601-2-56 standards and designrequirement as Predicate device. |
| Measurement means | Thermo-resistor type | Thermo-resistor type | Identical |
| Patient type | Adult, Pediatric (not neonatal): | Adult, Pediatric | Identical |
| Unit of measure | C or F | C or F | Identical |
| Measurement site | Body surface | Body surface | Identical |
| Temperature measurementrange | 21.0C to 50.0C (69.8F to 122F) | 32.0C to 43.9C (90F to 109.9F) | The difference in measurement rangedoes not raise any new questions ofsafety and effectiveness and stillcomplies with the ISO80601-2-56requirement same as Predicate device. |
| Temperature measurementaccuracy | ±0.2C(25.0C to 45.0C)±0.4C for the rest of the range | ±0.1C(35.0C to 39.0C)±0.2F(95.0F to 102.2F)±0.2C the rest | The difference in measurementaccuracy does not raise any newquestions of safety and effectivenessand still complies with the ISO80601-2-56 requirement same as Predicatedevice. |
{18}------------------------------------------------
Safety and Performance Data :
To establish substantial equivalence to the identified predicate devices, tests were completed as defined below to the subject devices, Patient Monitor, Models K10, K12. K15. The results of the testing demonstrate that the devices comply with the applicable standards requirements, and the devices are substantially equivalent to the predicate devices.
Non-Clinical Study:
Safety and EMC
- IEC 60601-1: 2005+A1: 2012 Medical electrical equipment Part 1: General requirements for basic safety and essential performance
- IEC 60601-1-2: 2014 Medical devices part 1-2: General requirements for basic safety and essential performance - Collateral standards: electromagnetic compatibility - Test and requirements
Performance Data:
- IEC 60601-2-49: Particular requirements for the basic safety and essential performance of multifunction patient monitoring equipment (2011)
- -ISO 80601-2-61 Second Edition 2017-12, medical electrical equipment - part 2-61: particular requirements for basic safety and essential performance of pulse oximeter equipment. (Anesthesiology)
- -ISO 80601-2-55 First edition 2011-12-15 Medical electrical equipment - Part 2-55: Particular requirements for the basic safety and essential performance of respiratory gas monitors
- IEC 60601-2-27 Medical Electrical Equipment Part 2-27: Particular Requirements -For The Basic Safety And Essential Performance Of Electrocardiographic Monitoring Equipment [Including Corrigendum 1 (2012)]
- ANSI AAMI EC53:2013 ECG trunk cables and patient lead wires -
- -IEC 80601-2-30 Edition 1.1 2013-07 Medical electrical equipment - Part 2-30: Particular requirements for the basic safety and essential performance of automated non-invasive sphygmomanometers
- -ISO 81060-2 Second edition 2013-05-01 Non-invasive sphygmomanometers - Part 2: Clinical validation of automated measurement type
- -ISO 80601-2-56 Second edition 2017-03 Medical electrical equipment - Part 2-56: Particular requirements for basic safety and essential performance of clinical thermometers for body temperature measurement.
- -IEC 60601-1-8 Edition 2.1 2012-11 Medical electrical equipment - Part 1-8: General requirements for basic safety and essential performance - Collateral Standard: General requirements, tests and guidance for alarm systems in medical electrical equipment and medical electrical systems
{19}------------------------------------------------
Biocompatibility
- ISO 10993-5: 2009 Biological evaluation of medical devices Part 5 Tests for In -Vitro Cytotoxicity
- ISO10993-10: 2010 Biological evaluation of medical Devices Part 10: Tests for -Irritation and Delayed-Type Hypersensitivity
- -The subject device is classified as a surface device and contact (hand, chest) for a limited duration.
Clinical Study:
- ISO 81060-2 Second edition 2013-05-01 Non-invasive sphygmomanometers Part -2: Clinical validation of automated measurement type
Conclusion:
The differences between subject devices and predicate device do not raise issues of safety and effectiveness based on the indication for use, technological characteristics, and performance testing. The subject device complies with the same applicable standards as the predicate device.
In accordance with the Federal Food, Drug and Cosmetic Act, 21 CFR Part 807 and based on the information provided in this premarket notification, the subject device, Patient Monitor, K10, K12, K15 is safe and effective and substantially equivalent to predicate devices as described herein
END
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).